Krakowski, Isabelle
Kim, Jiyeong http://orcid.org/0000-0002-2869-5751
Cai, Zhuo Ran
Daneshjou, Roxana http://orcid.org/0000-0001-7988-9356
Lapins, Jan
Eriksson, Hanna
Lykou, Anastasia
Linos, Eleni http://orcid.org/0000-0002-5856-6301
Funding for this research was provided by:
Foundation for the National Institutes of Health (K24AR075060, R01AR082109)
Radiumhemmets Forskningsfonder (009614, 211063, 181083)
Cancerfonden (2111617Pj, 210406JCIA01)
Vetenskapsrådet (202201534)
Stockholms Läns Landsting (FoUI-962339, FoUI-972654)
Article History
Received: 22 September 2023
Accepted: 5 February 2024
First Online: 9 April 2024
Competing interests
: H.E. has served in advisory roles and delivered presentations for Novartis, BMS, GSK and Pierre Fabre and has obtained industry-sponsored research funding from SkylineDx. RD is an AAD AI committee member and Associate Editor at the Journal of Investigative Dermatology, has received consulting fees from Pfizer, L’Oreal, Frazier Healthcare Partners, and has stock options in Revea and MDAlgorithms. All other authors declare no competing interests.